We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£795.00
The 2023-2028 World Outlook for Granulocyte Colony Stimulating Factor (G-CSF) Cancer Supportive Care
Price data last checked 26 day(s) ago - will refresh soon
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£795 today · cheaper than every other day in the last 3 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 65 days • 65 data points (No recent data available)
Price Distribution
Price distribution over 65 days • 1 price levels
Price Analysis
Most common price: £795 (65 days, 100.0%)
Price range: £795 - £795
Price levels: 1 different prices over 65 days
Product Specifications
- Format
- paperback
- ASIN
- B09YNFRT1T
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 10 May 2022
- Listed Since
- 06 May 2022
Similar Products You Might Like
The 2023-2028 Outlook for Cancer Supportive Care in the United States
The 2025-2030 World Outlook for Immune-Oncology Treatments
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
The 2021-2026 World Outlook for Circulating Tumor Cell (CTC) Technologies
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
The 2023-2028 Outlook for Cancer Screenings in the United States
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India
The 2025-2030 World Outlook for T-Cell Therapies
The 2023-2028 Outlook for Cancer Vaccines in India
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2023-2028 Outlook for Cancer Testing-Screening in India
The 2016-2021 Outlook for Hematology and Oncology Products in Greater China
The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in India
The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in India
The 2021-2026 World Outlook for Hematology and Oncology Products
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in the United States
The 2023-2028 Outlook for Cancer Vaccines in the United States
The 2025-2030 World Outlook for Immuno Oncology Assays
